Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $5 | $5 |
| % Growth | 1.9% | -1.8% | -4% | – |
| Cost of Goods Sold | $4 | $4 | $4 | $4 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 25.4% | 25.3% | 24.3% | 25% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 9.8% | 8.9% | 6.8% | 5.1% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 5.6% | 4.7% | 3.1% | 1.3% |
| EPS | 0.47 | 0.39 | 0.26 | 0.06 |
| % Growth | 20.5% | 50% | 333.3% | – |
| EPS Diluted | 0.47 | 0.39 | 0.26 | 0.06 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $0 |
| % Margin | 17.8% | 17.2% | 15.2% | 5.5% |